Nephrology nurses frequently care for patients with CKD who have side effects from hyperkalemia. This session discusses the challenges and a nephrology nurse’s role in planning care for these patients, including pharmacologic and non-pharmacologic measures.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures: There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure: There are no speaker disclosures to declare.
Commercial Support and Sponsorship: Supported through an educational grant from Vifor Pharma.
No other commercial support or sponsorship declared.
Accreditation Statement: The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome: Upon completion of this activity, the learner will state an increased ability to plan care for patients with CKD experiencing hyperkalemia.
PhD, APRN, RN, ACNP-BC,
University of Texas at Arlington
The Nephrology Nurse's Role in Managing Hyperkalemia in Patients with CKD (Sponsored by Vifor Pharma)
1.25 - CH
1.25 - Rx
You must be logged in and own this session in order to